HOME >> MEDICINE >> NEWS
New Treatment Under Investigation At University Of Maryland Could Dramatically Reduce Colon Cancer Deaths

An experimental new treatment for advanced colon cancer shows promise of saving thousands of lives a year, says a University of Maryland Medical Center physician who has begun clinical trials.

The therapy involves intravenous administration of two standard drugs and a newer drug in a different combination than the standard treatment. Early results from a similar study showed complete or partial remission in 96 percent of patients.

"Things are beginning to dramatically change in the way we treat colon cancer," says David Van Echo, M.D., an oncologist at the University of Maryland Greenebaum Cancer Center and professor of medicine and pharmacy at the University of Maryland School of Medicine.

"This new therapy is very promising for patients who have colon cancer that has recurred or spread to other organs," he says. The Phase-II trial involves giving the patient the drug CPT-11 (irinotecan) for 30 minutes, followed by leucovorin for 2 hours and a drug called 5-FU (5 fluorouracil) for 24 hours by intravenous drip. The patient begins therapy in the doctor's office but then goes home while the third drug is being infused.

"CPT-11 is a fairly new agent, leucovorin has been a standard treatment and 5-FU has been around for about 45 years," Dr. Van Echo explains. "What's new is this particular sequencing and a more frequent administration of the drugs at higher doses. Under current standards of care, the best that a patient with advanced colon cancer can expect is a reduction in the mortality rate from 60 percent to 50 percent. With this treatment we hope to get that down to 5 percent."

Van Echo stresses that this is just one of several approaches and that people with recurrent or metastasized cancer should seek out and enroll in clinical trials because it may be the only way for them to get some of the newer drugs and therapies. Also, enrolling in clinical trials has become easier for patients in Maryl
'"/>

Contact: Ira Allen
iallen@umms001.ab.umd.edu
410328-8919
University of Maryland Medical Center
2-Mar-1999


Page: 1 2 3

Related medicine news :

1. Treatment of cardiac lesions without anaesthesic
2. Treatment guidelines for kids with bipolar disorder published
3. University of Washington joins new Autism Treatment Network to provide better medical services
4. Treatment for brain tumor does not always follow recommendations
5. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
6. Treatment of ductal carcinoma in situ varies widely in United States
7. Treatment options expand for patients with neuropathic pain
8. Treatment interruption shows no benefit in drug-resistant HIV infection
9. Peanut Allergy: Major Advances in Treatment and Education
10. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
11. Treatment helped reduce dose of inhaled corticosteroids while maintaining asthma control

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2020)... VANCOUVER, Wash. (PRWEB) , ... January 10, 2020 , ... ... today announced their partnership in a new online community coming in February 2020, LEAD ... in the Health and Wellbeing Village. , The vision of LEAD WELL with WOMEN ...
(Date:1/10/2020)... ... 2020 , ... SMG3Rx, a clinical mobility platform powered by ... (Healthcare Information and Management Systems Society) Global Conference & Exhibition taking place on ... event of the year, where professionals throughout the global health ecosystem connect for ...
(Date:1/8/2020)... ... 2020 , ... Pyxa Solutions, a leading provider of consulting, ... is rebranding as Red Nucleus R&D, a division of Red Nucleus. Red Nucleus ... industry. , The addition of Red Nucleus R&D under the Red Nucleus ...
(Date:1/8/2020)... ... January 09, 2020 , ... Real ... Webinar, Thursday, Jan. 23, 2020 • 1:30-3:00 p.m. EST, https://www.centerwatch.com/rweanddata ... (RWD) to generate evidence and identify gaps and challenges when conducting trials? The ...
(Date:1/7/2020)... Texas (PRWEB) , ... January 07, 2020 , ... ... today unveiled another facility expansion, adding to the company’s 200,000 sq. ft. manufacturing ... 25,000 sq. ft. of manufacturing space dedicated to POD architectural, mechanical, electrical and ...
Breaking Medicine News(10 mins):
(Date:1/22/2020)... ... January 22, 2020 , ... Clairvoyant Networks, ... Care GPS remote monitoring and communications technology was selected for demonstration in the ... showcases the latest technology and services for consumers and businesses needing solutions that ...
(Date:1/12/2020)... ... January 10, 2020 , ... ... has been selected to present at next week’s Biotech Showcase. Cytonus is ... with its proprietary Cargocyte™ next generation Adoptive Cellular Therapy (ACT) technologies which ...
(Date:1/10/2020)... ... January 10, 2020 , ... Reach ... Counselor Association, will celebrate high school counselors and award the first annual Excellence ... National Championship weekend and Extra Yard for Teachers Summit celebration on Saturday, January ...
Breaking Medicine Technology:
Cached News: